talquetamab and teclistamab in rrmm: updated results from redirectt-1 | yael cohen, md | ims 2024
Published 9 days ago • 135 plays • Length 6:18Download video MP4
Download video MP3
Similar videos
-
3:29
clinical trial results for novel academic anti-bcma myeloma car-t cell | yael cohen, md | ims 2024
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
28:40
all about talvey (talquetamab)
-
5:29
updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
-
22:21
tecvayli (teclistamab) everything you need to know
-
7:25
updated phase 1 results of teclistamab, a bcma × cd3 bispecific antibody, in rrmm
-
55:56
talquetamab side effect management
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
10:55
modern chassidic medley
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
4:16
what is the monoclonal antibody talvey™ (talquetamab)?
-
1:14:09
healthtree podcast for multiple myeloma: teclistamab's approval with dr. garfall
-
2:13
introducing microbiome targeted technology™
-
6:31
real-world results from talquetamab and bispecific antibodies | carolina schinke, md | ash 2023
-
14:31
teclistamab - guest lecture
-
6:36
updated results of a phase 1, first-in-human study of talquetamab in relapsed refractory mm
-
58:00
know your myeloma immunotherapy: teclistamab and other bispecifics
-
3:44
what should myeloma patients know about talquetamab?
-
10:34
talquetamab - guest lecture
-
17:55
talquetamab | therapies on the horizon #myeloma
-
7:55
managing the unique side effects of talquetamamb | ajai chari, md | eha 2024